What's new

Orphan designation: amitriptyline Treatment of erythromelalgia, 21/06/2022 Withdrawn

Orphan designation: amitriptyline Treatment of erythromelalgia, 21/06/2022 Withdrawn

Feb 20, 2025 - 15:10
 0
Orphan designation: amitriptyline Treatment of erythromelalgia, 21/06/2022 Withdrawn
Orphan designation: amitriptyline Treatment of erythromelalgia, 21/06/2022 Withdrawn
Read More

Tags:

Previous Article

Orphan designation: Autologous CD34+ cells transfected with lentiviral vector co...

Next Article

Orphan designation: Adeno-associated viral vector serotype 9 containing the huma...

Related Posts

3Rs Working Party

3Rs Working Party

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Mounjaro, tirzepatide, Date of authorisation: 15/09/2022, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Alkindi, hydrocortisone, Date of authorisation: 09/02/2018, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0